Common Stock, Shares, Outstanding of enVVeno Medical Corp from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
enVVeno Medical Corp quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • enVVeno Medical Corp Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 20,216,000, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

enVVeno Medical Corp Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 20,216,000 +2,680,000 +15% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 19,247,000 +5,917,000 +44% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 17,536,000 +4,206,000 +32% 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 17,536,000 +4,219,000 +32% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 17,536,000 +8,064,000 +85% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 13,330,000 +3,858,000 +41% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 13,330,000 +3,858,000 +41% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 13,317,000 +3,845,000 +41% 31 Dec 2023 10-K/A 28 Feb 2025 2024 FY
Q3 2023 9,472,000 0 0% 30 Sep 2023 10-Q 26 Oct 2023 2023 Q3
Q2 2023 9,472,000 +2,000 +0.02% 30 Jun 2023 10-Q 31 Jul 2023 2023 Q2
Q1 2023 9,472,000 +2,000 +0.02% 31 Mar 2023 10-Q 28 Apr 2023 2023 Q1
Q4 2022 9,472,000 +2,000 +0.02% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 9,472,000 +3,676 +0.04% 30 Sep 2022 10-Q 27 Oct 2022 2022 Q3
Q2 2022 9,470,000 +956,338 +11% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 9,470,000 +962,110 +11% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 9,470,000 +6,928,471 +273% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 9,468,324 -30,774,410 -76% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 8,513,662 -15,435,671 -64% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 8,507,890 -10,723,967 -56% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 2,541,529 +1,824,255 +254% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 40,242,734 +22,320,605 +125% 30 Sep 2020 10-Q 17 Nov 2020 2020 Q3
Q2 2020 23,949,333 +6,027,204 +34% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 19,231,857 +5,076,213 +36% 31 Mar 2020 10-Q 08 Jun 2020 2020 Q1
Q4 2019 717,274 -11,005,373 -94% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 17,922,129 +6,204,822 +53% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 17,922,129 +6,204,822 +53% 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 14,155,644 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 11,722,647 +5,588,969 +91% 31 Dec 2018 10-K 18 Mar 2020 2019 FY
Q3 2018 11,717,307 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 11,717,307 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q4 2017 6,133,678 31 Dec 2017 10-K 14 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.